TL;DR: A BPC-157 reconstitution calculator converts vial size (typically 5mg) and bacteriostatic water volume into exact mcg-per-unit doses. The most common research ratio is 2mL water per 5mg vial, yielding 25mcg per 10-unit insulin syringe mark. Accurate math prevents under- or over-dosing in controlled studies.

Why BPC-157 Reconstitution Math Actually Matters

Peptide research lives and dies by precise measurement. When working with BPC-157 β€” a synthetic 15-amino-acid sequence derived from Body Protection Compound found in human gastric juice β€” even a small error in reconstitution volume translates directly into dose miscalculation. A researcher who adds 1mL of bacteriostatic water to a 5mg vial gets a concentration twice as strong as one who adds 2mL. Without a reliable BPC-157 reconstitution calculator, every downstream measurement in the protocol is compromised.

This guide walks through the complete reconstitution workflow: the math behind concentration ratios, how to interpret syringe units, common research volumes, and storage considerations. Use our interactive peptide calculator to run these numbers automatically.

Research Use Only: BPC-157 and all peptides referenced on this page are intended for laboratory research purposes only and are not approved for human consumption.

---

What Is BPC-157 and Why Is It Researched?

BPC-157 (Body Protection Compound 157) is a pentadecapeptide β€” a chain of 15 amino acids β€” with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is stable in human gastric juice and does not occur freely in nature; it was isolated from a larger precursor protein and then synthesized for research.

Research interest in BPC-157 centers on its apparent influence on the nitric oxide (NO) system, VEGF (vascular endothelial growth factor) upregulation, and modulation of growth hormone receptor expression. Multiple peer-reviewed rodent studies have documented accelerated tendon-to-bone healing, gastric mucosal protection, and angiogenesis in controlled models. Sikiric et al. (2018) published a comprehensive review in Current Pharmaceutical Design documenting its effects across gastrointestinal, musculoskeletal, and neurological models β€” without identified toxicity at studied doses.

BPC-157 Primary Research Mechanisms NO System Nitric oxide modulation VEGF Upregulation Promotes angiogenesis GH Receptor Expression modulation Cytoprotection Gastric mucosal integrity Tissue Repair & Homeostasis (musculoskeletal, GI, neurological models)

The BPC-157 Reconstitution Calculator: Core Formula

Reconstitution is the process of dissolving a lyophilized (freeze-dried) peptide powder into bacteriostatic water to create an injectable solution for research use. The fundamental formula is:

Concentration (mcg/mL) = Total Peptide Amount (mcg) Γ· Volume of Solvent Added (mL)

Since BPC-157 vials are most commonly supplied in 5mg (5,000mcg) amounts, here is how concentration changes with different water volumes:

Bacteriostatic Water Added Concentration mcg per 10 IU (0.1mL) mcg per 1 IU (0.01mL)
1 mL 5,000 mcg/mL 500 mcg 50 mcg
2 mL 2,500 mcg/mL 250 mcg 25 mcg
5 mL 1,000 mcg/mL 100 mcg 10 mcg
10 mL 500 mcg/mL 50 mcg 5 mcg

The 2mL per 5mg vial ratio is the most widely cited in published research protocols because it produces a 2,500 mcg/mL solution β€” granular enough for small doses without requiring impractically tiny volumes on a standard insulin syringe. Use the Capital Peptides calculator to enter any vial size and target dose to get your exact draw volume.

How to Read an Insulin Syringe for BPC-157 Reconstitution

Standard U-100 insulin syringes have 100 units per mL. Each unit (IU) therefore equals 0.01mL. Using the 2mL reconstitution example above (2,500 mcg/mL):

  • Target 250 mcg: Draw to the 10-unit mark (0.10 mL)
  • Target 500 mcg: Draw to the 20-unit mark (0.20 mL)
  • Target 125 mcg: Draw to the 5-unit mark (0.05 mL)

This is why reconstitution volume selection matters: if you use 1mL instead of 2mL, the same 10-unit draw delivers 500mcg instead of 250mcg β€” doubling the dose without any change to syringe technique.

Dose Output by Reconstitution Ratio (5mg Vial) mcg per 10-unit draw 500 mcg 1 mL water 5,000 mcg/mL 250 mcg 2 mL water βœ“ 2,500 mcg/mL 100 mcg 5 mL water 1,000 mcg/mL 50 mcg 10 mL water 500 mcg/mL Most used in research

Step-by-Step BPC-157 Reconstitution Protocol

The following describes a standard laboratory reconstitution procedure. This is documented for research reference only.

  1. Gather materials: BPC-157 lyophilized vial, bacteriostatic water (BAC water), alcohol swabs, insulin syringe, and a storage vial if needed.
  2. Wipe the vial stopper with an alcohol swab and allow it to dry for 30 seconds.
  3. Draw the BAC water into the syringe (e.g., 2mL for a standard 5mg vial).
  4. Inject the BAC water slowly down the inside wall of the vial β€” do not shoot it directly onto the powder, as this can degrade the peptide chain.
  5. Gently swirl (do not shake) until the powder is fully dissolved. The solution should be clear and colorless.
  6. Label the vial with the date reconstituted and the resulting concentration.
  7. Store refrigerated at 2–8Β°C. A reconstituted BPC-157 solution is generally considered stable for up to 4 weeks under refrigeration.

Using a BPC-157 Reconstitution Calculator for Common Research Protocols

Published rodent studies on BPC-157 commonly reference doses in the range of 1–10 mcg/kg body weight administered subcutaneously or intraperitoneally. Translating rodent effective doses directly to other research contexts requires careful allometric scaling β€” another function available through our peptide dosing calculator.

The most frequently cited research protocol in the peer-reviewed literature uses subcutaneous administration, referencing doses between 10mcg and 500mcg per session in rodent models. Sikiric's 2018 review cites the majority of positive musculoskeletal outcomes at the 10 mcg/kg range in Sprague-Dawley rats weighing approximately 300g β€” equating to roughly 3mcg total per animal.

Choosing the Right BPC-157 Reconstitution Ratio for Your Research

The "right" reconstitution ratio depends on the dose range being studied and the syringe resolution available:

  • High-dose protocols (>300 mcg per administration): A 1mL or 2mL reconstitution works well β€” doses correspond to manageable syringe volumes.
  • Mid-range protocols (100–300 mcg): 2mL is optimal; each 10-unit increment = 25mcg, providing fine resolution.
  • Low-dose protocols (<100 mcg): Consider 5mL or 10mL reconstitution to avoid drawing impractically small sub-unit volumes.

Bacteriostatic Water vs. Sterile Water for BPC-157

Bacteriostatic water (0.9% benzyl alcohol) is the preferred diluent for BPC-157 reconstitution in research settings for one key reason: multi-use stability. Benzyl alcohol inhibits bacterial growth, extending shelf life of the reconstituted solution. Sterile water contains no preservative and should be used only for single-use preparations, as contamination risk increases significantly after first puncture. The bacteriostatic water tag on our site covers this topic in further detail.

Storage, Degradation, and Stability Considerations

Lyophilized BPC-157 powder is substantially more stable than reconstituted solution. Key storage guidelines based on manufacturer data and published stability studies:

  • Lyophilized powder: Store at βˆ’20Β°C for long-term storage (up to 24 months); refrigerator temperature (2–8Β°C) is acceptable for up to 3 months.
  • Reconstituted solution: Refrigerate at 2–8Β°C; use within 28–30 days. Avoid freeze-thaw cycling of reconstituted solution.
  • Light exposure: Keep vials protected from light. UV exposure degrades peptide bonds over time.
  • Temperature excursions: Brief room-temperature exposure during handling is acceptable, but sustained warmth accelerates hydrolysis of the peptide chain.
BPC-157 Storage Stability Timeline Reconstituted ~28 days @ 2–8Β°C Lyophilized 3 months @ 2–8Β°C Lyophilized 24 months @ βˆ’20Β°C 0 6 months 12 months 18 months 24 months

BPC-157 in Research Stacks: Common Combinations

BPC-157 is frequently studied alongside TB-500 (Thymosin Beta-4) in tissue repair models. The mechanistic logic is complementary: BPC-157 appears to drive angiogenesis and fibroblast migration via the NO pathway, while TB-500 promotes actin polymerization and cellular migration. Together, the two peptides are hypothesized to address both the structural scaffolding and vascular supply needs of healing tissue.

Researchers also reference BPC-157 alongside growth hormone secretagogues in gut integrity models. Its gastroprotective profile β€” originally described in ulceration studies β€” makes it a candidate for GI-focused research protocols examining intestinal permeability and mucosal healing.

Safety Profile in Research Models

BPC-157 has not demonstrated significant toxicity in any peer-reviewed rodent study to date. No LD50 has been established, which is itself notable given the range of doses tested. Side effect observations in animal models have been minimal and have not included organ toxicity, endocrine disruption, or oncogenic signaling. However, long-term safety data in higher mammals and humans remains absent from the published literature β€” a critical gap that underscores its status as a research compound only.

From a peptide chemistry standpoint, BPC-157's oral stability (it resists gastric acid hydrolysis) is unusual among peptides, which has driven interest in both injectable and oral research delivery models.

Research Use Only Disclaimer: BPC-157 and all peptides described on this page are sold by Capital Peptides for laboratory research purposes only. They are not approved by the FDA for human use, and nothing in this article constitutes medical advice or a recommendation for self-administration.

Frequently Asked Questions

What is the standard BPC-157 reconstitution ratio for a 5mg vial?

The most commonly referenced ratio in published research protocols is 2mL of bacteriostatic water per 5mg vial, producing a concentration of 2,500 mcg/mL. This yields 25mcg per single insulin syringe unit (0.01mL), making mid-range doses easy to measure accurately. Use our peptide calculator to verify your specific numbers.

How long does reconstituted BPC-157 remain stable?

Reconstituted BPC-157 stored in bacteriostatic water and kept refrigerated at 2–8Β°C is generally considered stable for approximately 28–30 days. Lyophilized powder stored at βˆ’20Β°C retains potency for up to 24 months in most manufacturer stability data.

Can I use sterile water instead of bacteriostatic water for BPC-157?

Sterile water can be used for single-use preparations, but bacteriostatic water (containing 0.9% benzyl alcohol) is preferred for multi-use research vials because benzyl alcohol inhibits bacterial contamination over the weeks-long usage window. After first puncture, a sterile-water vial should be used immediately.

What is the BPC-157 dose range used in published animal studies?

Most peer-reviewed rodent studies reference doses in the 1–10 mcg/kg range administered subcutaneously or intraperitoneally. For a standard 300g rat, this translates to roughly 0.3–3 mcg total per dose. Allometric scaling calculators help transpose these figures across species for research planning purposes.

How does a BPC-157 reconstitution calculator work?

A reconstitution calculator takes three inputs: total peptide amount (in mg or mcg), volume of solvent added (in mL), and target dose (in mcg). It outputs the required draw volume per dose in mL and units on a U-100 insulin syringe. Our online calculator handles all three inputs automatically.

References

  1. Sikiric P, Hahm KB, Blagaic AB, et al. (2018). "Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract." Current Pharmaceutical Design, 24(18), 1990–2001. Documents mechanism of action, gastroprotection, and musculoskeletal healing data across rodent models. View source
  2. Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. (2011). "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." Journal of Applied Physiology, 110(3), 774–780. Demonstrates VEGF upregulation and fibroblast promotion in tendon repair models. View source
  3. Sikiric P, Seiwerth S, Rucman R, et al. (2013). "Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157." Current Medicinal Chemistry, 19(1), 126–132. Reviews cytoprotective and anti-inflammatory findings in GI research models with no observed toxicity at studied doses.
  4. Gwyer D, Bhattacharjee P, Bhattacharjee P. (2019). "Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing." Cell and Tissue Research, 377, 153–159. Summarizes nitric oxide pathway involvement in BPC-157's healing effects. View source
  5. Huang T, Zhang K, Sun L, et al. (2015). "Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro." Drug Design, Development and Therapy, 9, 2485–2499. Confirms angiogenic activity and wound-closure acceleration in controlled in vivo models. View source